Primary care rebate schemes (PCRS) are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to NHS South East London on GP prescribing expenditure for particular branded medicine(s).
The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies. Entering into a rebate does not constitute endorsement by NHS South East London of that product. We are unable to publish the full details of the PCRS because this information is commercially sensitive. Health professionals should always base their prescribing decisions primarily on assessments of their individual patients’ clinical circumstances.
There are a number of PCRS available. NHS South East London is signed up to the following PCRS:
| Companies Involved | Medicines covered | Borough/ NHS SEL Wide |
| Sanofi | Apidra | NHS South East London |
| Chiesi | Clenil rebate | NHS South East London |
| Chiesi | Fostair NEXTHaler | NHS South East London |
| Chiesi | Fostair MDI | NHS South East London |
| Ethypharm | Espranor rebate | NHS South East London |
| Merck Serono Limited | Glucophage rebate | NHS South East London |
| EthyPharm | Physeptone | NHS South East London |
| Takeda | Prostap | NHS South East London |
| Sanofi | Clexane | NHS South East London |
| Fontus | Aproderm emollients and barrier creams | NHS South East London |
| Abbot | Flash Glucose Monitoring Freestyle Libre | NHS South East London |